Two-thirds (67 per cent) of employers say there’s currently a shortage of skilled workers in their industry and 58 per cent anticipate a skilled labour shortage over the next five to 10 years, according to Benefits Canada’s 2024 Future of Work Survey. To reverse this trend, nearly three-quarters (72 per cent) of employers cited improving […]
A majority (65 per cent) of Canadian employers say they have or are working on implementing a diversity, equity and inclusion policy, while 44 per cent of this group said they’re focusing on DEI to attract and retain employees, according to Benefits Canada’s 2024 Future of Work Survey. It found around three-quarters (72 per cent) […]
An article on why a majority of Canadians are planning to switch jobs this year was the most-read story on BenefitsCanada.com this past week. Here are the top five human resources, benefits, pension and investment stories of the last week: 1. Six in 10 Canadian employees planning to change jobs this year: survey 2. Acera Insurance’s group […]
Advocacy on the federal government’s pharmacare program will continue to be a core focus for the Benefits Alliance in 2025, says Carolyne Eagan, the association’s president. As each province is determining how or whether they’ll accept the government-sponsored program, she says the association plans to continue its grassroots campaign to engage with Canadian plan sponsors […]
Benefits Canada’s Face to Face Drug Plan Management Forum has been running for nearly 20 years and is the industry’s most popular drug benefits conference. On Dec. 2 at the Omni King Edward Hotel in Toronto, attendees experienced a full day of educational sessions presented by industry experts, with insights into fresh drug plan designs […]
Attention deficit hyperactivity disorder is a neurodevelopmental disorder, affecting up to nine per cent of children and five per cent of adults, said Marie-Hélène Dugal, manager of pharmacy benefit strategy at Medavie Blue Cross, during Benefits Canada’s 2024 Face to Face Drug Plan Management Forum. Diagnosis rates have increased among women and become more common […]
Women face unique health challenges throughout their lives — across most age groups, women experience higher rates of chronic diseases compared to men, said Neda Nasseri, pharmacist and product director of drug benefits at Desjardins Insurance, during a session supported by Pfizer Canada at Benefits Canada’s 2024 Face to Face Drug Plan Management Forum. Historically, […]
Canada’s workforce increasingly reflects the unique health challenges faced by its female population. Between 2018 and 2023, women represented a little more than half of the total claimants and spend in Express Scripts Canada’s drug claims data, according to Farah Belayadi, the organization’s senior manager of clinical services and health technology database, during Benefits Canada’s […]
Breast cancer is the most common cancer in Canada, predominantly affecting women, with more than 29,000 diagnoses in 2023. It’s complexity is underscored by more than 50 unique types, making each diagnosis distinct and challenging to treat, according to Kimberly Carson, chief executive officer of Breast Cancer Canada, during a session supported by AstraZeneca Canada […]
Advances in medical science and innovations in drug development necessitate updated drug plan strategies, according to Frédéric Leblanc (pictured far right), strategic leader of drug programs, group benefits and retirement solutions at iA Financial Group. During a panel discussion supported by EMD Serono Inc., GSK, iA Financial Group, Merck & Co. Inc., Novo Nordisk Canada Inc. […]
aHR0cHM6Ly93d3cuYmVuZWZpdHNjYW5hZGEuY29tL3RhZy9oZWFsdGgtYmVuZWZpdHMvcGFnZS81Lw(U2NyZWVuSGVpZ2h0)NzIw(U2NyZWVuV2lkdGg)MTI4MA(T0ZTWVNfUmVmZXJyZXI)(dmlzaXRvcktleQ)Z2NqNEFKdHQ(dmlzaXRLZXk)SFNYYUZqakI){kind=small}